share_log

大参林医药集团股份有限公司2024年第三季度报告

Dashenlin Pharmaceutical Group Co., Ltd. Report for the third quarter of 2024

SZSI ·  Oct 30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more